These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1874479)

  • 21. [Abnormalities of structure and function of the thyroid in patients with alopecia areata].
    Broniarczyk-Dyła G; Lewiński A; Zerek-Meleń G; Sewerynek E; Woźniacka A
    Przegl Dermatol; 1989; 76(5-6):416-21. PubMed ID: 2641808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum thyroid-stimulating hormone and antimicrosomal antibodies as a screen for autoimmune thyroid disease.
    Bigos ST; Hindson D; McCallum J
    J Lab Clin Med; 1979 Jun; 93(6):1035-40. PubMed ID: 438605
    [No Abstract]   [Full Text] [Related]  

  • 23. Circulating immune complexes in various thyroid diseases.
    Brohee D; Delespesse G; Debisschop MJ; Bonnyns M
    Clin Exp Immunol; 1979 Jun; 36(3):379-83. PubMed ID: 487642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases.
    Lindholm E; Hallengren B; Agardh CD
    Diabetes Metab Res Rev; 2004; 20(2):158-64. PubMed ID: 15037992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Anti-thyroid antibodies and autoimmune diseases in patients with vitiligo].
    Peracchi M; Cavagnini F; Ghislanzoni G
    G Ital Dermatol Minerva Dermatol; 1971 Nov; 46(11):487-91. PubMed ID: 5171287
    [No Abstract]   [Full Text] [Related]  

  • 26. Environmental factors in autoimmune thyroid disease.
    Wiersinga WM
    Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 3():S67-70. PubMed ID: 10522808
    [No Abstract]   [Full Text] [Related]  

  • 27. [Iodine and autoimmune diseases of the thyroid gland].
    Gerasimov GA; Petunina NA
    Probl Endokrinol (Mosk); 1993; 39(3):52-4. PubMed ID: 8058685
    [No Abstract]   [Full Text] [Related]  

  • 28. [Autoimmune diseases and treatment with interferon-alpha: review of the literature apropos of a case of hyperthyroidism].
    Dupont J; Orgiazzi J; Burger A
    Rev Med Interne; 1993 Feb; 14(2):93-9. PubMed ID: 8378632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyroid disorders in 2 cases of acute myeloid leukaemia following treatment with recombinant interleukin-2 infusion.
    Lim SH; Callaghan T; Goldstone AH
    Acta Haematol; 1991; 85(1):49-50. PubMed ID: 2011933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoimmune thyroid disease in interferon-treated patients.
    Lancet; 1985 Jul; 2(8446):100-1. PubMed ID: 2861513
    [No Abstract]   [Full Text] [Related]  

  • 31. [Thyreoidismus medicamentosa, clinicopathological studies].
    Miyoshi K; Ohno F
    Nihon Naika Gakkai Zasshi; 1966 Aug; 55(5):462-7. PubMed ID: 6005710
    [No Abstract]   [Full Text] [Related]  

  • 32. Immune thrombocytopenia after alpha-interferon therapy in patients with cancer.
    Abdi EA; Venner PM
    JAMA; 1986 Apr; 255(14):1878-9. PubMed ID: 3951108
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term treatment with interferon-beta therapy for multiple sclerosis and occurrence of Graves' disease.
    Rotondi M; Mazziotti G; Biondi B; Manganella G; Del Buono AD; Montella P; di Cristofaro M; Di Iorio G; Amato G; Carella C
    J Endocrinol Invest; 2000 May; 23(5):321-4. PubMed ID: 10882151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Occurrence of thyroid autoimmunity and dysfunction throughout a nine-month follow-up in patients undergoing interferon-beta therapy for multiple sclerosis.
    Rotondi M; Oliviero A; Profice P; Mone CM; Biondi B; Del Buono A; Mazziotti G; Sinisi AM; Bellastella A; Carella C
    J Endocrinol Invest; 1998 Dec; 21(11):748-52. PubMed ID: 9972674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Interferon therapy and autoimmunity].
    Fritzsch J; Krug J; Heberling HJ
    Med Klin (Munich); 1997 May; 92(5):265-72. PubMed ID: 9244832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of transient thyroid disease and reaction during treatment of chronic hepatitis C with interferon.
    Kodama T; Katabami S; Kamijo K; Katanuma A; Yamashita K; Azuma N; Tamaki T; Yachi A
    J Gastroenterol; 1994 Jun; 29(3):289-92. PubMed ID: 8061797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical toxicity of the interferons.
    Vial T; Descotes J
    Drug Saf; 1994 Feb; 10(2):115-50. PubMed ID: 7516663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does interferon-beta therapy induce thyroid autoimmune phenomena?
    Pagliacci MC; Pelicci G; Schippa M; Liberati AM; Nicoletti I
    Horm Metab Res; 1991 Apr; 23(4):196-7. PubMed ID: 1874479
    [No Abstract]   [Full Text] [Related]  

  • 39. Development of autoimmune thyroid diseases during long-term treatment of hematological malignancies with alpha-interferons.
    Silvestri F; Virgolini L; Mazzolini A; Bertolissi F; Russo D; Fanin R; Baccarani M
    Haematologica; 1994; 79(4):367-70. PubMed ID: 7806093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The risk factor for development of thyroid disease during interferon-alpha therapy for chronic hepatitis C.
    Watanabe U; Hashimoto E; Hisamitsu T; Obata H; Hayashi N
    Am J Gastroenterol; 1994 Mar; 89(3):399-403. PubMed ID: 8122653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.